Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and...

Area of Science:

• Cardiovascular Research
• Stem Cell Biology
• Metabolic Diseases

Background:

• Diabetes mellitus poses a significant global health burden, with cardiovascular complications causing millions of deaths annually.
• Diabetic cardiomyopathy (DCM) is a major diabetes complication, characterized by progressive cardiac dysfunction and leading to heart failure.
• Current understanding of DCM pathogenesis is limited, necessitating advanced in vitro models for mechanistic studies.

Purpose of the Study:

• To review recent advances in modeling diabetic cardiomyopathy, with a focus on human induced pluripotent stem cell (iPSC)-based systems.
• To discuss the challenges and future directions in developing accurate in vitro models of DCM.
• To highlight the potential of iPSC-derived cardiomyocytes for investigating diabetes-related cardiac dysfunction.

Main Methods:

• Review of recent scientific literature on diabetic cardiomyopathy models.
• Analysis of preliminary data on iPSC-derived cardiomyocyte models of diabetes.
• Focus on iPSC technology for generating disease-specific cardiac cells.

Main Results:

• Human iPSC-derived cardiomyocytes can recapitulate key features of DCM, including insulin resistance and hypertrophy.
• Impaired calcium handling is observed in iPSC-derived cardiomyocytes modeling diabetic conditions.
• Generating cardiomyocytes with a fully representative diabetic metabolic and functional phenotype remains an ongoing challenge.

Conclusions:

• iPSC-based models show promise for studying diabetic cardiomyopathy mechanisms.
• These models can display specific diabetic cardiac phenotypes like insulin resistance and hypertrophy.
• Further refinement is required to fully replicate the complex metabolic and functional aspects of DCM in vitro.